Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers
NCT04725175
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
PIPE-307
DRUG:
Placebo oral tablet
Sponsor
Contineum Therapeutics